Individuals with T2DM frequently have multiple cardiovascular risk factors, including obesity (32.9%), hypertension (32-80%), and dyslipidemia (39%) ( The association between glycemic control and cardiovascular outcomes in DM patients has been long studied ( To address these challenges, novel pharmacological therapies such as sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged, offering cardioprotective benefits ( The aim of this review is to enhance our understanding of the role of SGLT-2i and GLP-1 RAs in managing patients with T2DM and CVD
You can't just waltz into your local Walgreen's or GNC and buy them, nor can you find them on Amazon
1-4 Together with lifestyle changes such as eating a healthier balanced diet and being more active, GLP-1 RAs help support weight loss
One question we often hear is whether it is safe and effective to combine topiramate with semaglutide
Ignoring Nutrient Synergy Many take glutathione in isolation, ignoring that it works best as part of an antioxidant network
They are commonly used in eyelash and eyebrow serums to promote longer, fuller lashes and brows
